Kestra Advisory Services’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.31M | Buy |
42,008
+3,831
| +10% | +$485K | 0.03% | 607 |
|
|
2025
Q1 | $4.88M | Buy |
38,177
+703
| +2% | +$89.9K | 0.02% | 582 |
|
|
2024
Q4 | $4.95M | Sell |
37,474
-4,730
| -11% | -$625K | 0.03% | 583 |
|
|
2024
Q3 | $6.14M | Sell |
42,204
-3,061
| -7% | -$446K | 0.03% | 527 |
|
|
2024
Q2 | $6.02M | Buy |
45,265
+7,586
| +20% | +$1.01M | 0.03% | 528 |
|
|
2024
Q1 | $5.17M | Sell |
37,679
-260
| -0.7% | -$35.7K | 0.03% | 507 |
|
|
2023
Q4 | $5.15M | Sell |
37,939
-1,690
| -4% | -$230K | 0.04% | 438 |
|
|
2023
Q3 | $4.85M | Buy |
39,629
+234
| +0.6% | +$28.6K | 0.05% | 400 |
|
|
2023
Q2 | $5M | Sell |
39,395
-4,991
| -11% | -$634K | 0.05% | 372 |
|
|
2023
Q1 | $5.73M | Sell |
44,386
-16,093
| -27% | -$2.08M | 0.06% | 313 |
|
|
2022
Q4 | $7.94M | Buy |
60,479
+10,990
| +22% | +$1.44M | 0.07% | 300 |
|
|
2022
Q3 | $5.79M | Sell |
49,489
-949
| -2% | -$111K | 0.06% | 337 |
|
|
2022
Q2 | $5.93M | Buy |
50,438
+315
| +0.6% | +$37.1K | 0.06% | 322 |
|
|
2022
Q1 | $6.53M | Buy |
50,123
+596
| +1% | +$77.7K | 0.07% | 308 |
|
|
2021
Q4 | $7.56M | Sell |
49,527
-8,715
| -15% | -$1.33M | 0.08% | 274 |
|
|
2021
Q3 | $9.42M | Buy |
58,242
+6,726
| +13% | +$1.09M | 0.09% | 235 |
|
|
2021
Q2 | $8.43M | Buy |
51,516
+362
| +0.7% | +$59.2K | 0.1% | 231 |
|
|
2021
Q1 | $7.7M | Sell |
51,154
-17,112
| -25% | -$2.58M | 0.1% | 240 |
|
|
2020
Q4 | $10.4M | Buy |
68,266
+17,991
| +36% | +$2.74M | 0.12% | 198 |
|
|
2020
Q3 | $6.81M | Buy |
+50,275
| New | +$6.81M | 0.13% | 192 |
|